In patients with end-stage kidney disease, a new testing method can better detect potentially fatal hormone imbalances. This is according to a recent study accepted for publication in The Endocrine Society's iJournal of Clinical Endocrinology (and) Metabolism/i (JCEM). At the end of 2009, more than 871,000 Americans were being treated for end-stage renal disease, according to the National Institutes of Health's National Institute of Diabetes and Digestive ...
Read More
No comments:
Post a Comment